Skip to content
Catalyst

(4S)-4-hydroxy-L-isoleucineFinding

(4S)-4-hydroxy-L-isoleucine increases HDL cholesterol

raisesInsufficient evidenceFindingreplicated ×1

01 · The sentence it was drawn from

“In diabetic rats, treatment with 4-hydroxyisoleucine did not affect glucose or liver damage markers, but did improve HDL-cholesterol levels (31% increase, p < 0.05).”
Quoted verbatim from The effect of fenugreek 4-hydroxyisoleucine on liver function biomarkers and glucose in diabetic and fructose-fed rats.
This finding among the 106 findings on its endpoint

(4S)-4-hydroxy-L-isoleucine

HDL cholesterol

raises

Who
streptozotocin-induced diabetic rats (described as a type 2 diabetes model)
Dose studied
not reported

Insufficient evidencePMID 18680121 · 2009

02 · The study

Study
animal · not in humans
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limited
  • insufficientthis finding

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7EX6MHBJD3YXVM03NAY6KZY